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Revisiting Heterochromatin in Embryonic Stem Cells
Irina Stancheva*
Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom
It is widely believed that chromatin in
embryonic stem (ES) cells exists in a
unique ‘‘open’’ conformation, character-
ized by sparse, disorganized heterochro-
matin and prevalent global transcription.
Upon differentiation, this ‘‘blueprint’’ of
pluripotent state is thought to undergo
dramatic remodelling. In this issue of PLoS
Genetics, Lienert and colleagues [1] revisit
heterochromatin and transcription in plu-
ripotent and terminally differentiated cells
to demonstrate that neither the abundance
of repressive histone H3 lysine 9 dimethy-
lation (H3K9me2) nor the net transcrip-
tional output of the genome discriminate
these two very different cell states.
Pluripotent ES cells, derived from the
inner cell mass of developing mammalian
blastocyst, have the distinctive ability to
self-renew in culture and differentiate into
multiple lineages when exposed to appro-
priate signals. The self-organizing regula-
tory network of transcription factors and
the epigenetic mechanisms that are in-
volved in maintenance of pluripotent state
and self-renewal are actively debated and
intensively studied by many laboratories
[2,3]. When induced to differentiate, ES
cells respond by changes in gene expres-
sion, cell morphology, and chromatin
structure, which may collectively contrib-
ute to a reduction in developmental
plasticity [4,5].
Several lines of evidence have suggested
that DNA in stem cells is packaged into an
unusually dynamic form of chromatin that
carries ES cell–specific patterns of histone
modifications. Thus, in ES cells, histone
H3 and H4 tend to be hyperacetylated;
constitutive heterochromatin foci, marked
by histone H3 lysine 9 trimethylation
(H3K9me3), are fewer and less well
organized; and histone and non-histone
chromatin-bound proteins, such as hetero-
chromatin protein 1 (HP1), are more
mobile [4,6,7]. In addition, a substantial
number of gene promoters in ES cells is
marked by closely juxtaposed active
(H3K4me3) and repressive (H3K27me3)
chromatin modifications [8,9]. This so-
called bivalent or poised chromatin is
resolved into a monovalent state at most,
but not all, loci upon differentiation [9,10].
However, repressive chromatin marks
come in several ‘‘flavours’’. Of those,
H3K9me2 is a relatively abundant mod-
ification associated with facultative hetero-
chromatin that covers large, gene-poor
regions of the genome [11]. It has been
reported that these H9K9me2 domains
are ‘‘minimally present’’ in ES cells, but
undergo substantial expansion and stabili-
zation in differentiated tissues, such as liver
and brain, resulting in transcriptional
silencing of genes residing in these do-
mains [11,12]. Further studies have found
that chromatin regions marked by other
repressive modifications, such as H3K-
9me3 and H3K27me3, are also larger in
lineage-restricted human lung fibroblasts
IMR90 when compared to human ES
cells. These regions undergo remodelling
and reduction in size upon reprogram-
ming of IMR90 cells into induced plurip-
otent stem cells (iPSCs) [10]. Collectively,
these observations suggest that lineage
commitment and differentiation are ac-
companied by expansion and stabilization
of repressive chromatin.
In order to investigate in detail the
changes in H3K9me2-marked heterochro-
matin domains during terminal differenti-
ation, Lienert et al. [1] used a robust in
vitro neurogenesis system to differentiate
ES cells into postmitotic pyramidal neu-
rons [13]. Profiles of H3K9me2, repre-
senting ,10% of the genome, including
the entire chromosome 19, were generated
for both cell types and compared to each
other. Surprisingly, it was found that these
profiles showed high degree of correlation
between ES cells and neurons. In both cell
types, H3K9me2 covered ,50% of chro-
mosome 19, and a very modest increase in
H3K9me2 (5%) was observed in termi-
nally differentiated neurons. In agreement
with an earlier study [11], H3K9me2 was
enriched at large chromosomal domains,
but those were generally invariable in
median size and distribution between ES
cells and neurons, and mutually exclusive
with active (H3K4me2) and other repres-
sive chromatin marks (H3K27me3). Some
discrete differences were observed; those
included gain of H3K9me2 over new large
domains in neurons, mostly over the
bodies of transcribed genes, as well as loss
of H3K9me2 from much smaller regions
(Figure 1). Furthermore, high throughput
sequencing of RNA (RNA-seq) from ES
cells, neurons, and, additionally, mouse
embryonic fibroblasts, showed well de-
fined cell type–specific expression, but no
significant overall difference in the tran-
scribed portion of the genome, including
most repetitive sequences. Although the
findings of Lienert et al. [1] seem to
disagree with previous studies [4,11], these
discrepancies could be largely explained
by methodological differences in the
analyses of H3K9me2 genomic microar-
ray data [12] and the accuracy in
discriminating between low and absent
transcription by microarrays, which may
suffer from crosshybridization, versus un-
ambiguous direct counting of RNA se-
quence reads [1]. As both Effroni et al. [4]
and Lienert et al. [1] have measured the
abundance of polyadenylated RNAs, re-
flecting mostly the productive transcrip-
tion, it might be interesting to employ
global nuclear run-on coupled with high
throughput sequencing (NRO-seq) [14] in
order to explore whether the extent of
non-productive transcription differs signif-
icantly between ES cells and terminally
differentiated neurons.
In summary, the observations of Lienert
et al. [1] highlight the remarkable conser-
vation of the facultative heterochromatin
domains and the global transcriptional
output of the genome between ES cells
Citation: Stancheva I (2011) Revisiting Heterochromatin in Embryonic Stem Cells. PLoS Genet 7(6): e1002093.
doi:10.1371/journal.pgen.1002093
Editor: Bas van Steensel, Netherlands Cancer Institute, The Netherlands
Published June 2, 2011
Copyright:  2011 Irina Stancheva. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
Funding: This work was supported by Cancer Research UK grant C7215/A8983 (http://www.cancerresearchuk.
org/). The funder had no role in the preparation of the article.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: istancheva@ed.ac.uk
PLoS Genetics | www.plosgenetics.org 1 June 2011 | Volume 7 | Issue 6 |  e1002093
and terminally differentiated neurons.
They also suggest that genome reprogram-
ming during lineage commitment and
differentiation is largely achieved by de-
velopmental cues and strong transcription
factors, which induce localized and highly
specific changes in heterochromatin rather
than promote genome-wide build up of
H3K9me2 and suppression of global low-
level transcription. Such a model is further
supported by findings that differentiation
of ES cells into neuronal progenitors and
then into astrocytes is accompanied by
focal, localized rearrangements in chro-
matin-nuclear lamina interactions, while
the overall architecture of lamina-associ-
ated chromosomal domains remains large-
ly preserved [15].
It cannot be completely ruled out that,
although quantitatively similar, hetero-
chromatin is qualitatively different, more
fluid and, perhaps, less essential in ES cells
than in terminally differentiated cells and
tissues. Such plasticity could be mediated
by chromatin remodelling ATPases, his-
tone acetyltransferases, and histone de-
methylases, some of which are highly
expressed in stem cells and essential for
pluripotency [4,16–18]. Is heterochroma-
tin then functional in ES cells?
The vast majority of H3K9me2 in the
genome is established by the euchromatic
histone methylases EHMT2 and EHMT1,
also known as G9a and GLP, respectively.
Similar to the knockouts of DNA methyl-
transferases [19], ES cells lacking either
G9a or GLP are viable and morphologi-
cally normal, but G9a2/2 and Glp2/2
embryos die in midgestation (E9–9.5)
[20,21]. This suggests that, although DNA
methylation and G9a/GLP-dependent
H3K9me2 are dispensable for self-renewal
in ES cells, they become vital during
differentiation and embryonic develop-
ment. Unfortunately, the differentiation
potential of G9a2/2 and Glp2/2 ES cells
has never been investigated in detail.
Nevertheless, these cells form embryonic
bodies upon induction with retinoic acid,
but fail to terminally silence OCT3/4 [22],
indicating that G9a/GLP-dependent het-
erochromatin formation may safeguard
rather than actively channel differentiation.
Despite the overwhelming evidence that
heterochromatin is present, but somewhat
‘‘wimpy’’ in stem cells, it was reported that
H3K9me2- and H3K9me3-specific his-
tone demethylases JMJD1A and JMJD2C,
respectively, are directly regulated by
OCT3/4 transcription factor and are
Figure 1. Chromatin landscapes in ES cells and terminally differentiated neurons. In ES cells, facultative heterochromatin domains marked
by H3K9me2 (blue) cover a large proportion of the genome (,53%). Terminal differentiation of ES cells into pyramidal neurons in vitro is
accompanied by net gain of H3K9me2 (,5%), mostly at new domains over the bodies of actively transcribed genes, and localized loss of H3K9me2
from much smaller regions. The focal loss of H3K9me2 could be induced by binding of specific transcription factors and modifiers (yellow/orange
circles) to gene regulatory regions. Importantly, the overall size and distribution of stable H3K9me2 domains remain largely unchanged. Promoters
carrying bivalent (active H3K4 [green] and repressive H3K27 [red]) marks are resolved into monovalent state during differentiation. Although different
and very specific sets of genes are expressed in ES cells and neurons, the overall global transcriptional output of the genome is conserved.
doi:10.1371/journal.pgen.1002093.g001
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essential for maintenance of pluripotency
[18]. Depletion of these enzymes by small
interfering RNAs (siRNAs) leads to accu-
mulation of H3K9me and unscheduled
differentiation. However, it was also clear-
ly shown that JMJD1A and JMJD2C
action is restricted to specific loci and
does not lead to ubiquitous removal of
H3K9me from the genome. Taken to-
gether with the studies of Lienert et al. [1],
these findings firmly indicate that hetero-
chromatin is functional in ES cells and has
to be actively remodelled in order to allow
the self-organizing network of transcrip-
tion factors to prevent differentiation and
promote self-renewal. The same general
principle of local heterochromatin remov-
al by lineage-specific transcriptional regu-
lators may operate during differentiation.
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